Clearwater Analytics Holdings, Inc. (NYSE:CWAN – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 6,970,000 shares, a growth of 15.8% from the March 31st total of 6,020,000 shares. Based on an average daily trading volume, of 1,200,000 shares, the short-interest ratio is presently 5.8 days. Approximately 6.8% of the company’s stock are short sold.
Clearwater Analytics Stock Down 1.6 %
CWAN opened at $15.78 on Wednesday. Clearwater Analytics has a 12 month low of $13.02 and a 12 month high of $21.89. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.15 and a quick ratio of 5.15. The stock has a market cap of $3.86 billion, a P/E ratio of -143.45, a P/E/G ratio of 6.51 and a beta of 0.45. The stock’s 50 day moving average price is $17.19 and its 200 day moving average price is $18.72.
Insider Transactions at Clearwater Analytics
In related news, CFO James S. Cox sold 10,000 shares of the stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $19.74, for a total value of $197,400.00. Following the completion of the transaction, the chief financial officer now owns 148,711 shares of the company’s stock, valued at $2,935,555.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Clearwater Analytics news, CEO Sandeep Sahai sold 50,000 shares of the company’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $19.74, for a total transaction of $987,000.00. Following the sale, the chief executive officer now owns 270,838 shares in the company, valued at $5,346,342.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO James S. Cox sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $19.74, for a total value of $197,400.00. Following the sale, the chief financial officer now owns 148,711 shares in the company, valued at approximately $2,935,555.14. The disclosure for this sale can be found here. Insiders sold 16,310,000 shares of company stock valued at $275,809,400 over the last quarter. Company insiders own 2.10% of the company’s stock.
Institutional Trading of Clearwater Analytics
Analysts Set New Price Targets
Several analysts have issued reports on the company. DA Davidson restated a “buy” rating and set a $24.00 price objective on shares of Clearwater Analytics in a research note on Monday, February 5th. Piper Sandler reiterated a “neutral” rating and set a $20.00 price target on shares of Clearwater Analytics in a research report on Thursday, February 29th. Finally, JPMorgan Chase & Co. cut Clearwater Analytics from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $24.00 to $22.00 in a research report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Clearwater Analytics currently has an average rating of “Moderate Buy” and a consensus target price of $22.00.
Read Our Latest Analysis on Clearwater Analytics
About Clearwater Analytics
Clearwater Analytics Holdings, Inc develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.
Recommended Stories
- Five stocks we like better than Clearwater Analytics
- Investing in the High PE Growth Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the S&P 500 and How It is Distinct from Other Indexes
- Hilton Demonstrates Asset Light is Right for Investors
- What does consumer price index measure?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Clearwater Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearwater Analytics and related companies with MarketBeat.com's FREE daily email newsletter.